Citadel Advisors’s NuCana NCNA Stock Holding History
Bought
Maintained
Sold
Other funds holding NCNA
Citadel Advisors's NCNA Position: Q3 2026 in Review
Citadel Advisors reduced its NuCana (NCNA) stake by 56% in Q3 2026, selling an estimated $20.7K and leaving 12,035 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13726.
Citadel Advisors first reported a position in NCNA in Q3 2017 and has held it in 17 quarters since. The position peaked at $1.22M in Q3 2017. 12 funds tracked by Wall St. Rank hold NCNA as of Q3 2026.
- Citadel Advisors held 12,035 shares of NuCana worth $16.2K as of Q3 2026.
- Citadel Advisors sold 15,064 NuCana shares in Q3 2026, an estimated $20.7K.
- NuCana made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13726 holding.
- Citadel Advisors first reported a position in NuCana in Q3 2017 and has held it in 17 quarters since.
- Citadel Advisors's NuCana position peaked at $1.22M in Q3 2017.
- 12 funds tracked by Wall St. Rank held NuCana as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.